Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Obstructive Lung Diseases

  Free Subscription


Articles published in Ann Allergy Asthma Immunol

Retrieve available abstracts of 105 articles:
HTML format



Single Articles


    May 2025
  1. KIM Y, Moonie S, Kim I, Yoo JW, et al
    Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
    Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
    PubMed    


  2. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
    Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
    Ann Allergy Asthma Immunol. 2025;134:535-538.
    PubMed    


  3. MURAI Y, Koya T, Koda H, Uji W, et al
    Dupilumab efficacy in relation to changes in club cell secretory protein 16.
    Ann Allergy Asthma Immunol. 2025;134:556-562.
    PubMed     Abstract available


    April 2025
  4. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
    The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
    Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
    PubMed     Abstract available


  5. SCOTT EA, Balasubramanian A, Brems JH, Wu TD, et al
    Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings.
    Ann Allergy Asthma Immunol. 2025 Apr 18:S1081-1206(25)00183.
    PubMed     Abstract available


  6. GARDNER DD, Gokani R, Hey-Hadavi J, Williams D, et al
    Healthcare-Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey.
    Ann Allergy Asthma Immunol. 2025 Apr 3:S1081-1206(25)00175.
    PubMed     Abstract available


  7. GRAYSON MH
    Asthma and evolving trends in allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;134:369.
    PubMed    


    March 2025
  8. KALRA S, Kalra D, Nagaraja N, Hlaing WM, et al
    Food Allergy and Asthma in a Nationally Representative Sample of Adolescents in the United States.
    Ann Allergy Asthma Immunol. 2025 Mar 28:S1081-1206(25)00152.
    PubMed    


  9. TO M, Arimoto Y, Honda N, Furusho N, et al
    Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00126.
    PubMed     Abstract available


  10. FAN H, Ren Z, Zhang P, Zhou B, et al
    Increased asthma burden during and post the COVID-19 pandemic among U.S. adults.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123.
    PubMed    


  11. VIINANEN A, Ilmarinen P, Mehtala J, Jylhava J, et al
    Factors associated with the development of severe asthma - a nationwide study (FINASTHMA).
    Ann Allergy Asthma Immunol. 2025 Mar 9:S1081-1206(25)00119.
    PubMed     Abstract available


  12. GELB AF, Tashkin DP
    Utility of using thoracic computed tomography to measure lung function decline and detect unsuspected emphysema in severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:253-254.
    PubMed    


  13. TANABE N
    Further evidence for the roles of computed tomography in managing severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:251-252.
    PubMed    


  14. MATHUR SK, Silver J, MacKnight SD, Urosevic A, et al
    Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
    Ann Allergy Asthma Immunol. 2025;134:341-350.
    PubMed     Abstract available


    February 2025
  15. LUGOGO NL, Gilbert IA, Gandhi HN, Tkacz JP, et al
    Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting beta(2)-agonist rescue.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00088.
    PubMed     Abstract available


  16. SKEEN E, Hamlington KL, De Keyser H, Liu AH, et al
    Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00092.
    PubMed     Abstract available


  17. CEGOLON L, Filon FL, Lange JH
    Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:125-126.
    PubMed    


  18. GALANT SP
    Oscillometry-determined small airway dysfunction as a significant risk for poor asthma control and exacerbations.
    Ann Allergy Asthma Immunol. 2025;134:123-124.
    PubMed    


    January 2025
  19. BRUZZESE JM, Cespedes A, Ainapudi V, Kingston S, et al
    Barriers to Seeing a Healthcare Provider among Rural Adolescents with Poorly Controlled Asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00046.
    PubMed    


  20. GREIG R, Chan R, Fardon TC, Lipworth BJ, et al
    Real world effects of tezepelumab on small airways dysfunction in severe refectory asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00064.
    PubMed    


  21. COTTINI M, Ventura L, Lombardi C, Landi M, et al
    Small airway dysfunction mediates the relationship between FeNO and asthma control.
    Ann Allergy Asthma Immunol. 2025 Jan 16:S1081-1206(25)00004.
    PubMed     Abstract available


  22. LEE JK, Pollard SJ, Liu MC, Schleich F, et al
    Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003.
    PubMed     Abstract available


  23. OPPENHEIMER J, Casale T
    Care of asthma-a rapidly moving story.
    Ann Allergy Asthma Immunol. 2025;134:1-2.
    PubMed    


    December 2024
  24. MILIGKOS M, Oh J, Kwon R, Konstantinou GNu, et al
    Epidemiology of asthma across the ages.
    Ann Allergy Asthma Immunol. 2024 Dec 12:S1081-1206(24)01727.
    PubMed     Abstract available


  25. ELLIOTT MR, O'Connor AE, Marshall GD
    Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
    Ann Allergy Asthma Immunol. 2024 Dec 7:S1081-1206(24)01716.
    PubMed    


  26. OU MC, Tsai RY, Li CP, Gau SY, et al
    Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:732-733.
    PubMed    


  27. CHAN R, Kuo CR, Fardon T, Thouseef MJ, et al
    The interplay between skeletal muscle adiposity and radiographic features of airway remodeling in persistent asthma.
    Ann Allergy Asthma Immunol. 2024;133:626-627.
    PubMed    


    November 2024
  28. ZHANG B, Yan M, Li C, Zhao J, et al
    Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01712.
    PubMed     Abstract available


  29. LANZ MJ, Chipps B, Zeiger RS, Bacharier LB, et al
    Pediatric Asthma Impairment and Risk Questionnaire: Rationale and Development of a Composite Control Tool.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01711.
    PubMed     Abstract available


  30. CONWAY AE, Marshall GD, Oppenheimer J, Shaker MS, et al
    Should Biologics Be Available for All Patients with Uncontrolled Asthma, Regardless? Absolutely and Here's Why.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01713.
    PubMed    


  31. GREIMANN E, Freigeh GE, Wettenstein RP, Nelson B, et al
    Mild Asthma- What Matters to Patients and Parents.
    Ann Allergy Asthma Immunol. 2024 Nov 26:S1081-1206(24)01708.
    PubMed     Abstract available


  32. DUCHARME FM, Chan R
    Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults: review article.
    Ann Allergy Asthma Immunol. 2024 Nov 25:S1081-1206(24)01702.
    PubMed     Abstract available


  33. GOCHICOA-RANGEL L, Vargas MH
    How best to choose an oscillometer and reference equations for your patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 16:S1081-1206(24)01681.
    PubMed     Abstract available


  34. COTTINI M, Lombardi C, Comberiati P, Berti A, et al
    Oscillometry-defined small airways dysfunction as a treatable trait in asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 15:S1081-1206(24)01658.
    PubMed     Abstract available


  35. ZHANG W, Li L, Zhang Y, Dai J, et al
    Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
    Ann Allergy Asthma Immunol. 2024 Nov 14:S1081-1206(24)01657.
    PubMed     Abstract available


  36. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunolo
    Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630.
    PubMed    


  37. YU JT, Gau SY, Li CP, Chang HC, et al
    Real-world association between cat ownership and asthma.
    Ann Allergy Asthma Immunol. 2024;133:613.
    PubMed    


  38. SHEN CY, Li CP, Tsai RY, Chang HC, et al
    Infant urinary adrenal steroids and childhood asthma development.
    Ann Allergy Asthma Immunol. 2024;133:611-612.
    PubMed    


  39. GRAYSON MH
    The future of allergy and immunology research: 2024 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2024;133:505-506.
    PubMed    


  40. ESCHENBACHER WH
    Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma.
    Ann Allergy Asthma Immunol. 2024;133:497-498.
    PubMed    


    October 2024
  41. RAO R, Han YY, Valentin-Rodriguez LA, Presto AA, et al
    Proximity to Fast-Food Restaurants and Pediatric Asthma Outcomes.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01631.
    PubMed    


  42. RUPPRECHT C, Krishnaswamy G
    OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01632.
    PubMed     Abstract available


  43. GALLEGOS-KOYNER FJ, Hodo F, Barrera NI, Cerrud-Rodriguez RC, et al
    Opioid Use Disorder's Impact on Asthma Hospitalizations: A Propensity Matched Nationwide Study.
    Ann Allergy Asthma Immunol. 2024 Oct 18:S1081-1206(24)01577.
    PubMed     Abstract available


  44. MANKA LA, Guntur VP, Stevens AD, Kolakowski C, et al
    The Supraglottic Index: An Indicator of Response to Laryngopharyngeal Reflux Therapy in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 15:S1081-1206(24)01573.
    PubMed     Abstract available


  45. ZIDAN E, Wilson G, Shin JJ, Chupp G, et al
    The Next Frontier: Defining and Optimizing Treatments for Patients with T2 Low Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 14:S1081-1206(24)01571.
    PubMed    


  46. SELUK L, Davis AE, Rhoads S, Wechsler ME, et al
    Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 9:S1081-1206(24)01552.
    PubMed     Abstract available


  47. MAILHOT-LAROUCHE S, Celis-Preciado C, Heaney LG, Couillard S, et al
    Identifying Super-Responders: a Review of the Road to Asthma Remission.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01559.
    PubMed     Abstract available


  48. GREIG R, Stewart K, Chan R, Lipworth B, et al
    Assessment of bronchodilator responsiveness using low frequency impedance in type 2 high uncontrolled severe asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01570.
    PubMed    


  49. BUSSE WW
    The Role of Biologics in Inducing Remission in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01557.
    PubMed     Abstract available


  50. MIYATA Y, Tanaka A, Ebato T, Kashima A, et al
    Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
    Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553.
    PubMed     Abstract available


  51. WEINBERGER MM, Hendeles L
    Biologics for asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:356-357.
    PubMed    


  52. CORELLI ER, Peebles RS Jr
    Race toward more equitable pulmonary function testing?
    Ann Allergy Asthma Immunol. 2024;133:362-363.
    PubMed    


  53. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
    Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
    PubMed    


    September 2024
  54. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
    Metabolic and weight components' impact on incident asthma using a real-world cohort.
    Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
    PubMed     Abstract available


  55. CHAN R, Lipworth B
    Airway oscillometry in asthma - present and future perspectives.
    Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
    PubMed    


  56. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
    Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
    Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
    PubMed     Abstract available


  57. SIM DW, Choi S, Jeong J, Lee SY, et al
    Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
    PubMed     Abstract available


  58. KAIDASHEV I, Ditiatkovskaya E
    Managing Asthma and Allergies during the Russo-Ukrainian War.
    Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
    PubMed    


  59. SHAMIM J
    The relationship of height and asthma.
    Ann Allergy Asthma Immunol. 2024;133:352.
    PubMed    


  60. PHILIPENKO BS, Davis B, Cockcroft DW
    To stop or not to stop an asthma biologic, that is the question.
    Ann Allergy Asthma Immunol. 2024;133:236-237.
    PubMed    


  61. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
    Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
    Ann Allergy Asthma Immunol. 2024;133:310-317.
    PubMed     Abstract available


    August 2024
  62. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
    Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
    Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
    PubMed     Abstract available


  63. HAGWOOD SR, Elliott M, Marshall GD
    Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
    Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
    PubMed    


  64. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
    Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
    PubMed    


  65. MALDONADO-PUEBLA M, Ledford D, Cardet JC
    The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024;133:123-124.
    PubMed    


  66. STEWART K, Kuo CR, Chan R, Lipworth B, et al
    Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
    Ann Allergy Asthma Immunol. 2024;133:211-213.
    PubMed    


    July 2024
  67. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
    Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
    PubMed     Abstract available


  68. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
    Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
    PubMed     Abstract available


  69. HAN YY, Celedon JC
    The Effects of Violence and Related Stress on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
    PubMed     Abstract available


  70. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
    Community Violence and Asthma: A Review.
    Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
    PubMed     Abstract available


  71. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
    Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
    Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
    PubMed     Abstract available


  72. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
    Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
    PubMed     Abstract available


  73. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
    Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
    PubMed     Abstract available


  74. SIM S, Jang JH, Park HS
    Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
    Ann Allergy Asthma Immunol. 2024;133:7-8.
    PubMed    


  75. GUTIERREZ CG, Bukstein DA
    Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
    Ann Allergy Asthma Immunol. 2024;133:5-6.
    PubMed    


  76. HARRIS D, Borish L
    How we treat type 2 low asthma.
    Ann Allergy Asthma Immunol. 2024;133:43-46.
    PubMed    


  77. MULLUR J, Buchheit KM
    Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
    Ann Allergy Asthma Immunol. 2024;133:118.
    PubMed    


    June 2024
  78. TRASANDE L
    The Role of Plastics in Allergy, Immunology and Human Health: What the Clinician Needs to Know and Can Do About It.
    Ann Allergy Asthma Immunol. 2024 Jun 28:S1081-1206(24)00417.
    PubMed     Abstract available


  79. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
    Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
    Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
    PubMed     Abstract available


  80. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
    Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
    Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
    PubMed     Abstract available


  81. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
    Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
    PubMed     Abstract available


  82. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
    Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
    Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
    PubMed     Abstract available


  83. ZEIGER JS, Silvers WS, Zeiger RS
    Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
    PubMed    


  84. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
    PubMed     Abstract available


  85. SEDAGHAT AR, Phillips KM
    Unifying the airway through multiomics.
    Ann Allergy Asthma Immunol. 2024;132:667-668.
    PubMed    


    May 2024
  86. BELLANTI JA, Settipane RA
    Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
    Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
    PubMed    


  87. PETERSEN M, Bingemann TA
    Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
    Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
    PubMed    


  88. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
    Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
    Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
    PubMed     Abstract available


  89. KLOEPFER KM, Kennedy JL
    Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
    Ann Allergy Asthma Immunol. 2024;132:553-554.
    PubMed    


  90. KATIAL RK, Hoyte FCL
    Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
    Ann Allergy Asthma Immunol. 2024;132:551-552.
    PubMed    


  91. BEIGELMAN A, Goss CW, Wang J, Srinivasan M, et al
    Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
    Ann Allergy Asthma Immunol. 2024;132:623-629.
    PubMed     Abstract available


    April 2024
  92. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
    The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
    Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
    PubMed     Abstract available


  93. WOO SD, Park HS, Yang EM, Ban GY, et al
    8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
    Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
    PubMed     Abstract available


    March 2024
  94. MOTA D, Martins C, Puga N, Moreira A, et al
    Asthma and allergy screening in elite football athletes: is it worth it?
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
    PubMed    


  95. LEE PH, An M, Hwang D, Jang AS, et al
    Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
    PubMed    


  96. HUANG D, Zhang L, Liu Y, Wang J, et al
    Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
    PubMed     Abstract available


  97. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
    Evidence for two clusters among non-eosinophilic asthmatics.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
    PubMed     Abstract available


  98. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
    Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
    PubMed     Abstract available


  99. LI Y, Hong X, Chandran A, Keet CA, et al
    Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
    Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
    PubMed     Abstract available


  100. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
    Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
    Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
    PubMed     Abstract available


    February 2024
  101. CETIN GP, Yilmaz I
    What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
    Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
    PubMed    


  102. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
    PubMed    


    January 2024
  103. CHEN C, Song X, Murdock DJ, Marcus A, et al
    Association between allergic conditions and COVID-19 susceptibility and outcomes.
    Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
    PubMed     Abstract available


    November 2023
  104. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
    Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
    PubMed     Abstract available


  105. GEVAERT P, Mullol J, Saenz R, Ko J, et al
    Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.